These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9369448

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG.
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [Abstract] [Full Text] [Related]

  • 23. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
    Schoneberg T, Yun J, Wenkert D, Wess J.
    EMBO J; 1996 Mar 15; 15(6):1283-91. PubMed ID: 8635461
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
    Los EL, Deen PM, Robben JH.
    J Neuroendocrinol; 2010 May 15; 22(5):393-9. PubMed ID: 20163515
    [Abstract] [Full Text] [Related]

  • 26. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
    Schöneberg T, Schulz A, Biebermann H, Grüters A, Grimm T, Hübschmann K, Filler G, Gudermann T, Schultz G.
    Hum Mutat; 1998 May 15; 12(3):196-205. PubMed ID: 9711877
    [Abstract] [Full Text] [Related]

  • 27. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
    Vandergheynst F, Pradier O, Beukinga I, Kornreich A, Vassart G, Decaux G.
    Eur J Clin Invest; 2012 Mar 15; 42(3):254-9. PubMed ID: 21834801
    [Abstract] [Full Text] [Related]

  • 28. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
    Neocleous V, Skordis N, Shammas C, Efstathiou E, Mastroyiannopoulos NP, Phylactou LA.
    Metabolism; 2012 Jul 15; 61(7):922-30. PubMed ID: 22386940
    [Abstract] [Full Text] [Related]

  • 29. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
    Gitelman SE, Feldman BJ, Rosenthal SM.
    Am J Med; 2006 Jul 15; 119(7 Suppl 1):S54-8. PubMed ID: 16843086
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Intrafamilial phenotype variability in nephrogenic diabetes insipidus.
    Kalenga K, Persu A, Goffin E, Lavenne-Pardonge E, van Cangh PJ, Bichet DG, Devuyst O.
    Am J Kidney Dis; 2002 Apr 15; 39(4):737-43. PubMed ID: 11920339
    [Abstract] [Full Text] [Related]

  • 32. Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones.
    Szalai L, Sziráki A, Erdélyi LS, Kovács KB, Tóth M, Tóth AD, Turu G, Bonnet D, Mouillac B, Hunyady L, Balla A.
    Front Pharmacol; 2022 Apr 15; 13():811836. PubMed ID: 35153784
    [Abstract] [Full Text] [Related]

  • 33. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG, Turner M, Morin D.
    Proc Assoc Am Physicians; 1998 Apr 15; 110(5):387-94. PubMed ID: 9756088
    [Abstract] [Full Text] [Related]

  • 34. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2006 Aug 15; 291(2):F257-70. PubMed ID: 16825342
    [Abstract] [Full Text] [Related]

  • 35. Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach.
    Mutig K, Borowski T, Boldt C, Borschewski A, Paliege A, Popova E, Bader M, Bachmann S.
    Am J Physiol Renal Physiol; 2016 Aug 01; 311(2):F411-23. PubMed ID: 27306979
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
    Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, Bouvier M.
    J Clin Invest; 2000 Apr 01; 105(7):887-95. PubMed ID: 10749568
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.